JB Chemicals & Pharmaceuticals has received an approval to buy-back up to 12.5 lakh shares, representing 1.47% of total paid up share capital, at Rs 400 per share for a total consideration not exceeding Rs 50 crore, through the tender offer route on a proportionate basis. The board of directors at its meeting held on May 23, 2017 had approved for the same.
JB Chemicals & Pharmaceuticals is one of India’s fastest growing pharmaceutical companies. The Company is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules.
